Richard A. Pollak, DPM, MS, FACFAS

Should You Use Oral Drugs For Onychomycosis?

01/03/2002

Patients with onychomycosis are becoming increasingly aware that oral antifungals have the potential to cure their underlying infections, yet a recent study finds the majority of podiatrists continue to rely largely on debridement to provide...

Patients with onychomycosis are...

01/03/2002

Podiatry Today

Case Study

Could Efinaconazole 10% Have An Impact For Onychomycosis?

01/22/2013

Richard A. Pollak , DPM, MS, FACFAS;

Can an emerging topical hold promise for onychomycosis? This author takes a closer look in this case study of a 24-year-old patient with distal lateral subungual onychomycosis.

Can an emerging topical hold...

01/22/2013

Podiatry Today

Online Exclusive

The Impact Of New Topical Antifungals On Onychomycosis Management

10/02/2017

Richard A. Pollak , DPM, MS, FACFAS;

Boni E. Elewski , MD;

Antonella Tosti , MD;

Tracey C. Vlahovic , DPM, FFPM, RCPS(Glasg);

These authors share their experience with the efficacy of new topical agents for onychomycosis, when to combine topical and oral therapy, and what the future may bring.

These authors share their...

10/02/2017

Podiatry Today

Roundtable Insights On Treating Onychomycosis

04/20/2011

Adam S. Landsman , DPM, PhD, FACFAS;

Allen Mark Jacobs , DPM, FACFAS, FAPWCA;

Bryan C. Markinson , DPM, FASPD, ABPM, DABPM;

Richard A. Pollak , DPM, MS, FACFAS;

Mark Kosinski , DPM, FIDSA, MA;

Warren S. Joseph , DPM, FIDSA;

Given the prevalence of onychomycosis and the emergence of laser therapy, these panelists review their approaches to managing onychomycosis, discuss ethical considerations with non-FDA approved modalities and emphasize the importance of...

Given the prevalence of...

04/20/2011

Podiatry Today

How To Treat Onychomycosis In Diabetic Patients

03/03/2003

Richard A. Pollak , DPM, MS, FACFAS;

Diabetes mellitus is a major health problem in the United States, afflicting approximately 17 million people, with 1 million new cases diagnosed each year in people 20 and older.1 Patients with diabetes are at increased risk for toenail...

Diabetes mellitus is a major...

03/03/2003

Podiatry Today

Current Trends In Antifungal Therapy

05/03/2002

Benjamin D. Overley Jr., DPM, FACFAS;

Richard A. Pollak , DPM, MS, FACFAS;

Aditya K. Gupta , MD, PhD;

Jack Rubinlicht , DPM;

Warren S. Joseph , DPM, FIDSA;

Should you use a topical, an oral therapy or a combination of both? This is one of many questions that came up during an intriguing discussion of antifungals. Drawing upon their clinical experience, the panelists discuss their approaches to...

Should you use a topical, an...

05/03/2002

Podiatry Today